Advertisement

Cardioprotective effect of hyperkalemic cardioplegia in an aquaporin 7-deficient murine heart

  • Masahiro FujiiEmail author
  • Keisuke Ota
  • Ryuzo Bessho
Original Article
  • 44 Downloads

Abstract

Background

Hyperkalemic cardioplegia using St. Thomas’ Hospital solution No. 2 (STH2) is commonly used to protect the myocardium during surgery. Mice deficient in the myocyte channel aquaporin 7 (AQP7) show significantly reduced glycerol and ATP contents and develop obesity; however, the influence of AQP7 on cardioplegia effectiveness remains unclear.

Methods

After determining the influence of ischemic duration on cardiac function, isolated hearts of male wild-type (WT) and AQP7-knockout (KO) mice (> 13 weeks old) were aerobically Langendorff-perfused with bicarbonate buffer, and randomly allocated to the control group (25 min of global ischemia) and STH2 group (5 min of STH2 infusion before 20 min of global ischemia, followed by 60 min of reperfusion).

Results

Final recovery of left ventricular developed pressure (LVDP) of WT and AQP7-KO hearts in the control group was 24.5 ± 12.4% and 20.6 ± 8.4%, respectively, which were significantly lower than those of the STH2 group (96.4 ± 12.7% and 92.9 ± 27.6%). Troponin T levels of WT and AQP-KO hearts significantly decreased in the STH2 groups (142.9 ± 27.2 and 219.9 ± 197.3) compared to those of the control (1725.0 ± 768.6 and 1710 ± 819.9).

Conclusions

AQP7 was not involved in the protective efficacy of STH2 in this mouse model, suggesting its clinical utility even in complications of metabolic disease.

Keywords

Mouse Aquaporin 7 Cardioplegia Ischemia–reperfusion Cardioprotection 

Notes

Acknowledgements

The authors wish to thank Dr. Norikazu Maeda, Dr. Tohru Funabashi, and Dr. Iichiro Shimomura (Department of Internal Medicine and Molecular Science, Osaka University, Osaka, Japan) for providing the AQP7-KO mice. We also would like to thank Dr. Kazutora Mizukami (PhD in Statistical Science, President of Medical Data Management, Fukuoka, Japan) for statistical assistance, Dr. Toshio Akimoto (PhD in Veterinary Medicine, Laboratory Animal Science, Nippon Medical School) for assistance with genotyping analysis, and Ms. Akina Kimura for assistance with the experiments. We are grateful to Dr. David J. Chambers (Cardiac Surgical Research, The Rayne Institute, St Thomas’ Hospital, London, UK) for academic advice. We would also like to thank Editage (www.editage.com) for English language editing.

Funding

This work was supported by JSPS KAKENHI Grant Number JP17K10740.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther. 2010;127:41–52.CrossRefGoogle Scholar
  2. 2.
    Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg. 1993;105:52–8.PubMedGoogle Scholar
  3. 3.
    Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL. STS National Database Committee. A decade of change–risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg. 2002;73:480–9.CrossRefGoogle Scholar
  4. 4.
    Sellke N, Gordon C, Lawandy I, Gorvitovskaia AY, Scrimgeour LA, Fingleton JG, et al. Impaired coronary contraction to phenylephrine after cardioplegic arrest in diabetic patients. J Surg Res. 2018;230:80–6.CrossRefGoogle Scholar
  5. 5.
    Osipov RM, Robich MP, Feng J, Clements RT, Liu Y, Glazer HP, et al. Effect of thrombin fragment (TP508) on myocardial ischemia–reperfusion injury in hypercholesterolemic pigs. J Appl Physiol. 2009;106:1993–2001.CrossRefGoogle Scholar
  6. 6.
    Rojek A, Praetorius J, Frøkiaer J, Nielsen S, Fenton RA. A current view of the mammalian aquaglyceroporins. Annu Rev Physiol. 2008;70:301–27.CrossRefGoogle Scholar
  7. 7.
    Butler TL, Au CG, Yang B, Egan JR, Tan YM, Hardeman EC, et al. Cardiac aquaporin expression in humans, rats, and mice. Am J Physiol Heart Circ Physiol. 2006;291:H705–13.CrossRefGoogle Scholar
  8. 8.
    Hibuse T, Maeda N, Nakatsuji H, Tochino Y, Fujita K, Kihara S, et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Cardiovasc Res. 2009;83:34–41.CrossRefGoogle Scholar
  9. 9.
    Marrades MP, Milagro FI, Martínez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun. 2006;339:785–9.CrossRefGoogle Scholar
  10. 10.
    Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W, et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA. 2005;102:10993–8.CrossRefGoogle Scholar
  11. 11.
    Maeda N, Funahashi T, Hibuse T, Nagasawa A, Kishida K, Kuriyama H, et al. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci USA. 2004;101:17801–6.CrossRefGoogle Scholar
  12. 12.
    Dutra RF, Mendes RK, Lins da Silva V, Kubota LT. Surface plasmon resonance immunosensor for human cardiac troponin T based on self-assembled monolayer. J Pharm Biomed Anal. 2007;43:1744–50.CrossRefGoogle Scholar
  13. 13.
    Peterson BT, Brooks JA, Zack AG. Use of microwave oven for determination of postmortem water volume of lungs. J Appl Physiol Respir Environ Exerc Physiol. 1982;52:1661–3.PubMedGoogle Scholar
  14. 14.
    Hibuse T, Maeda N, Nagasawa A, Funahashi T. Aquaporins and glycerol metabolism. Biochim Biophys Acta. 2006;1758:1004–11.CrossRefGoogle Scholar
  15. 15.
    Yeh JI, Charrier V, Paulo J, Hou L, Darbon E, Claiborne A, et al. Structures of enterococcal glycerol kinase in the absence and presence of glycerol: correlation of conformation to substrate binding and a mechanism of activation by phosphorylation. Biochemistry. 2004;43:362–73.CrossRefGoogle Scholar
  16. 16.
    Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med. 2002;8:1122–8.CrossRefGoogle Scholar
  17. 17.
    Shalaby A, Mennander A, Rinne T, Oksala N, Aanismaa R, Narkilahti S, et al. Aquaporin-7 expression during coronary artery bypass grafting with diazoxide. Scand Cardiovas J. 2011;45:354–9.CrossRefGoogle Scholar
  18. 18.
    Yan Y, Huang J, Ding F, Mei J, Zhu J, Liu H, et al. Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. Int J Mol Med. 2013;31:637–43.CrossRefGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2019

Authors and Affiliations

  1. 1.Department of Cardiovascular SurgeryNippon Medical School Chiba Hokusoh HospitalInzaiJapan

Personalised recommendations